Literature DB >> 29906533

Methylglyoxal modified IgG generates autoimmune response in rheumatoid arthritis.

Sidra Islam1, Abdul Rouf Mir1, Minhal Abidi1, Mohd Talha1, Atif Zafar2, Safia Habib1.   

Abstract

The detection of autoantibodies generated against modified proteins that stimulate cellular and humoral immune response has developed a lot of interest in the recent years and a search for biomarkers for the early detection of diseases has increased. IgG protein has earned attention for its possible modifications under hyperglycaemic conditions in rheumatoid arthritis, wherein dicarbonyl stress has been reported to alter the structural integrity of the protein. This report suggests that the interaction of the methylglyoxal with the IgG has consequences in the autoimmunopathology of rheumatoid arthritis. Our molecular docking analysis of methylglyoxal and IgG revealed a close interaction between the two molecules. TNBS studies confirmed the interaction by showing a decline in free lysine-arginine content post-MG modifications in IgG. The modified IgG was thermally more stable and showed the generation of glycation adducts N-epsilon-carboxyethyllysine. Rheumatoid arthritis patients showed enhanced carbonyl stress which was expected to induce structural changes in the epitope makeup of IgG. The ELISA studies and gel retardation assay confirmed auto-antibodies against MG modified IgG (MG-IgG) pointing towards the generation of neoepitopes upon IgG after interaction with MG. This study establishes the IgG modification in RA patients under alter carbonyl concentrations.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Advanced glycation end products; Immunoglobulin G; Methylglyoxal; Oxidative stress; Rheumatoid arthritis

Mesh:

Substances:

Year:  2018        PMID: 29906533     DOI: 10.1016/j.ijbiomac.2018.06.040

Source DB:  PubMed          Journal:  Int J Biol Macromol        ISSN: 0141-8130            Impact factor:   6.953


  2 in total

1.  Calf Thymus DNA Exposed to Quinacrine at Physiological Temperatures and pH Acquires Immunogenicity: A Threat for Long Term Quinacrine Therapy.

Authors:  Kumari Suganthy Asha; Safia Habib; Shahid Ali Siddiqui; Asif Ali
Journal:  Indian J Clin Biochem       Date:  2021-10-20

2.  Advanced Glycation End-Products (AGEs) and Their Soluble Receptor (sRAGE) in Women Suffering from Systemic Lupus Erythematosus (SLE).

Authors:  Agnieszka Nowak; Brygida Przywara-Chowaniec; Aleksandra Damasiewicz-Bodzek; Dominika Blachut; Ewa Nowalany-Kozielska; Krystyna Tyrpień-Golder
Journal:  Cells       Date:  2021-12-13       Impact factor: 6.600

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.